Position
Squarepoint Ops LLC in Vir Biotechnology, Inc.
Back to the book · All holders of VIR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $61.1K$6.03 → $8.96
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 20.9K | $125.8K | — | — | — | 0.0% |
| Q1 2026 | 26K | $233.1K | $8.96 | $61.1K | $46.1K | 0.0% |